Stocks Comparison
Abbott Laboratories vs Bristol Myers Squibb: revenue, profit, margins and growth compared
Abbott Laboratories brought in $44.3B of revenue in fiscal 2025, Bristol Myers Squibb $48.2B in fiscal 2025. Revenue changed by +5.7% at Abbott Laboratories and -0.2% at Bristol Myers Squibb on the year before, so Abbott Laboratories grew faster. Abbott Laboratories kept 14.7% of its revenue as net profit, Bristol Myers Squibb 14.6%. Free cash flow was $7.4B at Abbott Laboratories and $12.8B at Bristol Myers Squibb.
Side by side, latest fiscal year
| ABT | BMY | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $44.3B | $48.2B |
| Revenue growth | +5.7% | -0.2% |
| Net income | $6.5B | $7.1B |
| Net margin | 14.7% | 14.6% |
| Free cash flow | $7.4B | $12.8B |
| Free cash flow margin | 16.7% | 26.7% |
| Earnings per share (diluted) | $3.72 | $3.46 |
| Cash | $8.5B | $10.2B |
| Debt | $12.9B | $44.8B |
| Price to earnings | 27.2 | 18.2 |
| Market value | $175.3B | $128.4B |
| Dividend yield | 2.37% | 3.96% |
| Rank by revenue in sector | #18 of 523 · Health care | #16 of 523 · Health care |
Over the years
Questions about Abbott Laboratories and Bristol Myers Squibb
Which is bigger by revenue, Abbott Laboratories or Bristol Myers Squibb?
Bristol Myers Squibb is bigger by revenue: $48.2B in fiscal 2025, against $44.3B for Abbott Laboratories in fiscal 2025.
Which keeps more of its revenue as profit, Abbott Laboratories or Bristol Myers Squibb?
Abbott Laboratories had a net margin of 14.7% in fiscal 2025; Bristol Myers Squibb had 14.6% in fiscal 2025.
Which grew revenue faster, Abbott Laboratories or Bristol Myers Squibb?
In their latest fiscal years revenue changed by +5.7% at Abbott Laboratories and -0.2% at Bristol Myers Squibb.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.